Detalhe da pesquisa
1.
Target product profiles: tests for tuberculosis treatment monitoring and optimization.
Bull World Health Organ
; 101(11): 730-737, 2023 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37961060
2.
Unfavourable treatment outcomes in tuberculosis patients with different vitamin D status and blood glucose levels in a programme setting in China.
Trop Med Int Health
; 25(3): 373-379, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31802572
3.
Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis.
Emerg Infect Dis
; 22(3)2016 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-26885674
4.
Building a tuberculosis-free world: The Lancet Commission on tuberculosis.
Lancet
; 393(10178): 1331-1384, 2019 Mar 30.
Artigo
Inglês
| MEDLINE | ID: mdl-30904263
5.
Advances in clinical trial design for development of new TB treatments-Translating international tuberculosis treatment guidelines into national strategic plans: Experiences from Belarus, South Africa, and Vietnam.
PLoS Med
; 16(10): e1002896, 2019 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31626628
6.
Principles for designing future regimens for multidrug-resistant tuberculosis.
Bull World Health Organ
; 92(1): 68-74, 2014 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-24391302
7.
Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis.
J Antimicrob Chemother
; 68(2): 284-93, 2013 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-23054996
8.
Tuberculosis and antimicrobial resistance - new models of research and development needed.
Bull World Health Organ
; 95(5): 315, 2017 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28479629
9.
Pediatric Tuberculosis Research and Development: Progress, Priorities and Funding Opportunities.
Pathogens
; 11(2)2022 Jan 21.
Artigo
Inglês
| MEDLINE | ID: mdl-35215073
10.
Barriers to new drug development in respiratory disease.
Eur Respir J
; 47(1): 356-7, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26721975
11.
Why tobacco control should be a priority agenda item of Joint External Monitoring Missions for TB control?
Indian J Tuberc
; 68S: S93-S100, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34538400
12.
Tuberculosis recurrence over a 7-year follow-up period in successfully treated patients in a routine program setting in China: a prospective longitudinal study.
Int J Infect Dis
; 110: 403-409, 2021 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-34332089
13.
The time to act is now: pseudo-systematic review.
BMJ
; 371: m4143, 2020 12 10.
Artigo
Inglês
| MEDLINE | ID: mdl-33303482
14.
New opportunities in tuberculosis prevention: implications for people living with HIV.
J Int AIDS Soc
; 23(1): e25438, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31913556
15.
Resistance to second-line drugs in multidrug-resistant tuberculosis.
Lancet
; 381(9867): 625, 2013 Feb 23.
Artigo
Inglês
| MEDLINE | ID: mdl-23439097
16.
Lifesaving, cost-saving: Innovative simplified regimens for drug-resistant tuberculosis.
PLOS Glob Public Health
; 2(11): e0001287, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36962626
17.
Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda.
PLoS One
; 11(5): e0155968, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27223622
18.
New developments in the treatment of drug-resistant tuberculosis: clinical utility of bedaquiline and delamanid.
Infect Drug Resist
; 8: 367-78, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26586956
19.
Getting it right for children: improving tuberculosis treatment access and new treatment options.
Expert Rev Anti Infect Ther
; 13(4): 451-61, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25739933
20.
Towards early inclusion of children in tuberculosis drugs trials: a consensus statement.
Lancet Infect Dis
; 15(6): 711-20, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25957923